Correction: J Exp Clin Cancer Res 43, 144 (2024)
Following publication of the original article [1], an incorrect spelling was spotted in Fig. 6h of the published article. The tumor sample grouping as “PAX6 + shSTAT5A” should be corrected to “shPAX6 + STAT5A”.
Furthermore, errors were also spotted in the Supplementary Materials:
-
1.
Supplement material 1: In the a-panel of Figure S3, the authors omitted to mark the significant difference of the qPCR result and now have added it according to the description in the text.
-
2.
The “Additional information” file of this paper should be deleted because it is not the final version of the supporting data.
-
3.
Supplement material 1: In the h-panel of Figure S5, the authors misspelled the name of the tumor sample grouping as “PAX6 + shSTAT5A”. The correct spelling should be “shPAX6 + STAT5A”.
-
4.
Supplementary material 6 should be deleted because it is the response figure which is included in our response to the reviewers’ comments for argument and is also partially repeated to the supplementary material 1.
-
5.
Supplementary material 7 should be deleted because it is actually the supplementary figure S7 and its relevant figure legend which have been included in the supplementary material 1.
The corrections do not affect the overall result or conclusion of the article. The original article has been corrected.
Incorrect Figure 6
Correct Figure 6
References
Jing N, Du X, Liang Y, et al. PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5A-mediated chromatin accessibility. J Exp Clin Cancer Res. 2024;43:144. https://doi.org/10.1186/s13046-024-03064-1.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Jing, N., Du, X., Liang, Y. et al. Correction: PAX6 promotes neuroendocrine phenotypes of prostate cancer via enhancing MET/STAT5Amediated chromatin accessibility. J Exp Clin Cancer Res 43, 167 (2024). https://doi.org/10.1186/s13046-024-03084-x
Published:
DOI: https://doi.org/10.1186/s13046-024-03084-x